Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ | Lind Global Fund II LP | 9,210 0.400% | 9,210 (New Position) | Filing History |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 6.000% | 5,697 (New Position) | Filing History |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | Golden Minerals Company AUMN | Lind Global Fund II LP | 1,502,477 9.900% | 142,477 (+10.48%) | Filing History |
| 2024-02-13 8:02 pm Sale | 2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Lind Global Fund II LP | 0 0.000% | -3,000,000 (Position Closed) | Filing History |
| 2024-02-13 8:02 pm Purchase | 2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Lind Global Fund II LP | 44,750 1.800% | 44,750 (New Position) | Filing History |
| 2024-02-13 8:00 pm Sale | 2023-12-31 | 13G | Talphera, Inc. TLPH | Lind Global Fund II LP | 735,296 4.200% | -367,648 (-33.33%) | Filing |
| 2024-02-13 7:59 pm Purchase | 2023-12-31 | 13G | ABVC BioPharma, Inc. ABVC | Lind Global Fund II LP | 770,000 9.900% | 770,000 (New Position) | Filing History |
| 2024-02-09 09:00 am Purchase | 2024-02-06 | 13G | Cingulate Inc. CING | Lind Global Fund II LP | 23,500 9.900% | 23,500 (New Position) | Filing History |
| 2024-02-07 4:42 pm Purchase | 2024-02-02 | 13G | Sintx Technologies, Inc. SINT | Lind Global Fund II LP | 4,325 9.900% | 3,038 (+235.92%) | Filing History |
| 2024-02-06 5:28 pm Purchase | 2024-02-01 | 13G | Sidus Space, Inc. SIDU | Lind Global Fund II LP | 222,200 8.300% | 222,200 (New Position) | Filing History |
| 2024-02-06 5:26 pm Purchase | 2024-01-30 | 13G | Seelos Therapeutics, Inc. SEEL | Lind Global Fund II LP | 11,022 9.900% | 11,022 (New Position) | Filing History |
| 2024-01-18 4:28 pm Sale | 2023-12-31 | 13G | FingerMotion, Inc. FNGR | Lind Global Fund II LP | 1,000 1.000% | -3,214,296 (-99.97%) | Filing History |
| 2024-01-04 4:31 pm Purchase | 2023-12-27 | 13G | Netcapital Inc. NCPL | Lind Global Fund II LP | 20,286 9.900% | 20,286 (New Position) | Filing History |
| 2024-01-04 4:30 pm Purchase | 2023-12-26 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Lind Global Fund II LP | 426 9.900% | 426 (New Position) | Filing History |
| 2023-12-12 5:01 pm Purchase | 2023-12-12 | 13G | GSE Systems, Inc. GVP | Lind Global Fund II LP | 272,189 9.900% | 272,189 (New Position) | Filing History |
| 2023-12-07 4:30 pm Purchase | 2023-12-04 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 68 9.900% | 68 (New Position) | Filing History |
| 2023-12-06 4:30 pm Purchase | 2023-12-05 | 13G | Polar Power, Inc. POLA | Lind Global Fund II LP | 142,857 5.900% | 142,857 (New Position) | Filing History |
| 2023-11-29 4:33 pm Purchase | 2023-11-22 | 13G | PaxMedica, Inc. Common Stock PXMD | Lind Global Fund II LP | 450,000 9.900% | 450,000 (New Position) | Filing History |
| 2023-11-09 4:32 pm Purchase | 2023-11-08 | 13G | Golden Minerals Company AUMN | Lind Global Fund II LP | 1,360,000 9.900% | 1,360,000 (New Position) | Filing History |
| 2023-10-20 4:58 pm Purchase | 2023-10-17 | 13G | Versus Systems Inc. VS | Lind Global Fund II LP | 153,125 9.900% | 153,125 (New Position) | Filing History |